DF Dent & Co’s AbbVie ABBV Stock Holding History

DF Dent & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.62M	Sell	25,819 -8,458	-25%	-$1.88M	0.11%	109
2025 Q4	$7.83M	Buy	34,277 +613	+2%	+$140K	0.11%	102
2025 Q3	$7.79M	Buy	33,664 +5,120	+18%	+$1.04M	0.1%	104
2025 Q2	$5.3M	Buy	28,544 +687	+2%	+$128K	0.07%	109
2025 Q1	$5.84M	Sell	27,857 -65	-0.2%	-$12.6K	0.08%	109
2024 Q4	$4.96M	Buy	27,922 +110	+0.4%	+$20.2K	0.06%	112
2024 Q3	$5.49M	Buy	27,812 +194	+0.7%	+$36.2K	0.07%	108
2024 Q2	$4.74M	Buy	27,618 +196	+0.7%	+$32.5K	0.06%	102
2024 Q1	$4.99M	Buy	27,422 +281	+1%	+$48.4K	0.06%	103
2023 Q4	$4.21M	Buy	27,141 +5,625	+26%	+$820K	0.06%	99
2023 Q3	$3.21M	Sell	21,516 -333	-2%	-$48.9K	0.05%	112
2023 Q2	$2.94M	Buy	21,849 +1,221	+6%	+$179K	0.04%	112
2023 Q1	$3.29M	Buy	20,628 +1,207	+6%	+$185K	0.05%	106
2022 Q4	$3.14M	Buy	19,421 +1,895	+11%	+$291K	0.05%	111
2022 Q3	$2.35M	Buy	17,526 +3,933	+29%	+$564K	0.04%	115
2022 Q2	$2.08M	Buy	13,593 +3,241	+31%	+$495K	0.03%	114
2022 Q1	$1.68M	Buy	10,352 +813	+9%	+$118K	0.02%	130
2021 Q4	$1.29M	Sell	9,539 -616	-6%	-$72.8K	0.01%	138
2021 Q3	$1.09M	Hold	10,155	–	–	0.01%	139
2021 Q2	$1.14M	Sell	10,155 -58	-0.6%	-$6.53K	0.01%	138
2021 Q1	$1.1M	Hold	10,213	–	–	0.01%	136
2020 Q4	$1.09M	Hold	10,213	–	–	0.01%	132
2020 Q3	$895K	Sell	10,213 -100	-1%	-$9.41K	0.01%	134
2020 Q2	$1.01M	Buy	10,313 +250	+2%	+$22K	0.02%	124
2020 Q1	$767K	Buy	10,063 +91	+0.9%	+$7.75K	0.01%	135
2019 Q4	$883K	Hold	9,972	–	–	0.01%	148
2019 Q3	$755K	Buy	9,972 +1,000	+11%	+$68.6K	0.01%	151
2019 Q2	$652K	Buy	8,972 +1,150	+15%	+$90.4K	0.01%	159
2019 Q1	$630K	Hold	7,822	–	–	0.01%	162
2018 Q4	$721K	Buy	7,822 +80	+1%	+$7.04K	0.02%	160
2018 Q3	$732K	Sell	7,742 -1,000	-11%	-$94.8K	0.02%	173
2018 Q2	$810K	Hold	8,742	–	–	0.02%	156
2018 Q1	$827K	Buy	8,742 +1,209	+16%	+$133K	0.02%	160
2017 Q4	$729K	Sell	7,533 -149	-2%	-$14K	0.02%	131
2017 Q3	$683K	Sell	7,682 -139	-2%	-$10.6K	0.02%	112
2017 Q2	$567K	Hold	7,821	–	–	0.02%	115
2017 Q1	$510K	Hold	7,821	–	–	0.01%	111
2016 Q4	$490K	Sell	7,821 -334	-4%	-$20.4K	0.01%	123
2016 Q3	$514K	Hold	8,155	–	–	0.01%	109
2016 Q2	$505K	Hold	8,155	–	–	0.01%	125
2016 Q1	$466K	Sell	8,155 -700	-8%	-$39K	0.01%	108
2015 Q4	$525K	Hold	8,855	–	–	0.01%	108
2015 Q3	$482K	Hold	8,855	–	–	0.01%	109
2015 Q2	$595K	Buy	8,855 +139	+2%	+$9.07K	0.02%	130
2015 Q1	$510K	Hold	8,716	–	–	0.01%	113
2014 Q4	$570K	Buy	8,716 +700	+9%	+$44.1K	0.01%	106
2014 Q3	$463K	Sell	8,016 -1,350	-14%	-$74.9K	0.01%	115
2014 Q2	$529K	Sell	9,366 -1,200	-11%	-$63K	0.01%	112
2014 Q1	$543K	Sell	10,566 -8,181	-44%	-$413K	0.01%	113
2013 Q4	$990K	Sell	18,747 -1,200	-6%	-$59K	0.02%	92
2013 Q3	$892K	Hold	19,947	–	–	0.02%	92
2013 Q2	$825K	Buy	+19,947	New	+$872K	0.02%	91

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DF Dent & Co's ABBV Position: Q1 2026 in Review

DF Dent & Co reduced its AbbVie (ABBV) stake by 25% in Q1 2026, selling an estimated $1.88M and leaving 25,819 shares worth $5.62M. The position accounts for 0.11% of the portfolio, ranked #109.

DF Dent & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.83M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

DF Dent & Co held 25,819 shares of AbbVie worth $5.62M as of Q1 2026.
DF Dent & Co sold 8,458 AbbVie shares in Q1 2026, an estimated $1.88M.
AbbVie made up 0.11% of DF Dent & Co's portfolio in Q1 2026, its #109 holding.
DF Dent & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
DF Dent & Co's AbbVie position peaked at $7.83M in Q4 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DF Dent & Co's 13F filing for Q1 2026, filed 15 May 2026.